GILD vs PDM · P/E 18, rev $29.44B vs rev $570.3M
Gilead Sciences Inc (GILD) versus Piedmont Office Realty Trust Inc (PDM) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Piedmont Office Realty Trust Inc (PDM) is a reit - office company listed on US.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported PDM revenue for 2024-12-31 was $570.3M. Net income was -$79.1M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. PDM currently screens at market cap $905.7M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. PDM currently screens at market cap $905.7M.
Not investment advice. Open the GILD and PDM stock pages for the full models.
Not investment advice.